Sodium taurocholate is a GPBAR1 protein agonist potentially for the treatment of type 2 diabetes and obesity in rats. References: Liang HY, Chen T, Wang T, Huang Z, Yan HT, Tang LJ. Time course of intestinal barrier function injury in a sodium taurocholate-induced severe acute pancreatitis in rat model. J Dig Dis. 2014 Jul;15(7):386-93. doi: 10.1111/1751-2980.12148. PubMed PMID: 24690434.

纯度：≥98%

CAS：145-42-6